CompletedNot applicableNCT02288585

The Effect of Plant Sterols on the Blood Lipid Profile of Subjects With and at High Risk of Type 2 Diabetes Mellitus

Studying Sterol metabolism disorder

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Unilever R&D
Principal Investigator: Manny Noakes
Commonwealth Scientific and Industrial Research Organisation, Australia
Intervention: Plant sterols(dietary_supplement)
Enrollment: 150 target
Eligibility: 30-75 years · All sexes
Timeline: 2014 – 2016

Study locations (2)

CSIRO, Adelaide, Australia
CSIRO, North Ryde, Sydney, Australia

Collaborators

Commonwealth Scientific and Industrial Research Organisation, Australia

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02288585 on ClinicalTrials.gov

Other trials for Sterol metabolism disorder

Additional recruiting or active studies for the same condition.

RECRUITINGNANCT06481020
Plant Sterols on Cardiovascular Markers, Microbiota and Sterol Metabolism (Cardiofoodsterol)
University of Valencia

See all trials for Sterol metabolism disorder →

← Back to all trials